---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-22-002578"
form_type: "8-K/A"
ticker: "YBGJ"
cik: "0000895464"
company_name: "Yubo International Biotech Ltd"
filed_at: "2022-12-07T23:59:59+00:00"
generated_at: "2026-06-21T08:30:05.053346+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Yubo International amends share agreement to settle $819,229 in loans with World Precision Medicine

## Summary
- Gross proceeds of $819,229 from 1,638,458 shares at $0.50 will settle all outstanding loan principal and accrued interest.
- Upon delivery, Company has no further repayment obligations and any liens are automatically released.
- Amendment is retroactive to September 2, 2022, executed December 6, 2022, clarifying use of proceeds.
- Shares issued in a registered direct offering under effective S-1 registration statement.

## SEC filing metadata
- accession: 0001640334-22-002578
- form_type: 8-K/A
- ticker: YBGJ
- cik: 0000895464
- company_name: Yubo International Biotech Ltd
- filed_at: 2022-12-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/0001640334-22-002578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/yubo_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-22-002578
- JSON: https://secwatch.observer/filing/0001640334-22-002578.json
- Plain text: https://secwatch.observer/filing/0001640334-22-002578.txt

## Key facts
- Material Agreements
  Yubo International Biotech Ltd entered into Securities Purchase Agreement with World Precision Medicine Technology Limited valued at $819,229 (effective 2022-09-02).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: World Precision Medicine Technology Limited
  - Value: $819,229
  - Effective: 2022-09-02
  source text: On September 2, 2022, Yubo International Biotech Limited, a New York Corporation (the “ Company ”) entered into a Securities Purchase Agreement with World Precision Medicine Technology Limited (the “ Purchaser ”), as further amended by an Amendment to Securities Purchase Agreement, effective as of September 2, 2022, by and between the Company and the Purchaser (as amended, the “ Securities Purchase Agreement ”), pursuant to which the Company agreed to sell and issue to the Purchaser an aggregate of 1,638,458 shares (the “ Shares ”) of Class A Common Stock, par value $0.001 per share, of the Company, at $0.50 per share, for gross proceeds of $819,229.
  evidence_url: https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/0001640334-22-002578-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.